transplant patients treated with PSL and cyclosporine
METHODS

ated.
Methods. Twelve hypercholesterolemic kidney transplant Thirty-seven renal transplant patients immunosuppatients with serum total cholesterol Ն250 mg/dl without diabepressed with PSL and cyclosporine A and who had serum tes mellitus or hypoproteinemia were prospectively treated creatinine (Cr) levels of less than 3 mg/dl satisfied the with probucol (250 mg, bid, for three months). Before initiating inclusion criteria for this study. None were diabetic paand at the end of treatment, blood was drawn after at least a 12-tients or demonstrated hypoproteinemia or proteinuria. higher were submitted to a prospective treatment with
Results. After treatment with probucol, serum total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density probucol (Sinlestal; 250 mg, bid, for three months; Daiilipoprotein (HDL) cholesterol, and apo AI were significantly chi Seiyaku, Co., Tokyo, Japan) after obtaining their decreased, whereas cholesterol ester increased significantly. kg within three-months post-transplant. The follow-up period after transplantation ranged from 5 to 76 months (mean 37.4 Ϯ 4.9 months), and the latest serum Cr levels Hyperlipidemia is a well-known complication in kidranged from 0.9 to 2.9 mg/dl (mean 1.9 Ϯ 0.5 mg/dl). ney transplant recipients. However, opinions in the literBefore starting and after completing probucol adminisature differ concerning the prevalence and the type of tration, venous blood was drawn after at least 12-hour lipoprotein abnormalities. Reported changes of serum fasting. Serum was separated at room temperature, and lipids include an increase in total cholesterol and triglycthe total cholesterol, TG, and phospholipid (PL) levels eride (TG) levels, as well as an increase in very lowimmediately measured with an autoanalyzer. Apos A, density lipoprotein (VLDL) and LDL cholesterol con-B, CII, CIII, and E were determined by cytochrome tents [1, 2] . These changes may be causally related to immunoassay, lipoprotein fraction by ultracentrifugamultiple factors, including medication, such as prednisotion, lethicin acyl transferase (LCAT) by liposome sublone (PSL) [3] and cyclosporine [4, 5] 
